Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PERQ-UP: PERT in Pancreaticoduodenectomy
NCT05466838Active, not recruiting
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Jan 2023
- Primary completion
- May 2024
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial in pancreatic exocrine insufficiency (EPI) comparing PERT plus Standard of Care with Standard of Care (2 arms). Primary endpoints: Proportion of patients screened who consent, Proportion of patients screened who meet eligibility criteria and 3 more. Started Jan 2023; status: active, not recruiting.
02
Drugs
pancrelipase
03
Conditions
pancreatic exocrine insufficiency (EPI)
Beyond the preview
Go deeper on NCT05466838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05466838.